DeepCura Becomes the First Agentic Native Company in U.S. Healthcare: Inside the Architecture

DeepCura is positioning itself as a new kind of healthcare technology company—one built from the ground up around AI agents rather than traditional software structures.

Founded by Fernando Cowan, the company operates with just two human employees supported by seven autonomous AI agents that manage core business functions, including onboarding, documentation, billing, and even inbound sales. According to the company, roughly 80% of its operational workload is handled by AI.

This “agentic native” approach differs from most healthcare AI vendors, which typically layer AI features onto existing systems. Instead, DeepCura has designed both its platform and internal operations around AI from the outset, creating a tightly integrated system where the same tools used by clinicians also run the company itself.

At the center of this architecture is a network of specialized AI agents. These include an onboarding assistant that configures clinical systems through voice interactions, an AI receptionist that manages patient communications and scheduling, and an AI scribe that generates clinical documentation using multiple AI models simultaneously. Additional agents handle patient intake, billing processes, and company-level customer interactions.

A key advantage of this model is continuous improvement. Because the platform learns from both internal operations and customer interactions, updates and optimizations can be applied across all users in real time, rather than through periodic software releases. This creates a feedback loop where performance improves continuously as the system scales.

DeepCura also emphasizes interoperability and security. Its platform integrates with multiple electronic health record systems using standardized protocols, allowing clinical data to flow directly into patient records without manual input. The infrastructure is designed for high reliability and compliance with healthcare data standards, including HIPAA.

From a cost perspective, the company argues that its AI-driven operations significantly reduce overhead, enabling lower pricing compared to traditional vendors. Early feedback from clinicians evaluating AI tools has highlighted integration depth and pricing transparency as key decision factors—areas where the agentic model aims to offer an edge.

More broadly, DeepCura sees its approach as part of a larger shift in how organizations are built. Rather than scaling through headcount, companies may increasingly rely on networks of AI agents to handle operational complexity, allowing smaller teams to deliver at scale.

While still an emerging model, DeepCura presents a case study in how deeply embedded AI could reshape not only healthcare workflows, but the structure of technology companies themselves.